Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04675710
Title Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Stanford School of Medicine RECRUITING Stanford California 94304 United States Details
University of Michigan Rogel Cancer Center RECRUITING Ann Arbor Michigan 48109 United States Details
Mayo Clinic RECRUITING Rochester Minnesota 55901 United States Details
Cleveland Clinic Taussig Cancer Institute RECRUITING Cleveland Ohio 44195 United States Details
M D Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Huntsman Cancer Institute at the University of Utah RECRUITING Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field